Compound Detail
CHEMBL87045
CIFENLINE 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL87045 |
| Name | CIFENLINE |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | IPOBOOXFSRWSHL-UHFFFAOYSA-N |
4
Targets
7
Activities
1
Assay Types
10
PK Parameters
20
Publications
5
Known Names
1
Indications
Molecular Properties
262.4
MW (Da)
2.99
ALogP
2
HBA
1
HBD
24.4
PSA (Ų)
0.90
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Racemic |
Indications
Arrhythmias, Cardiac
ATC Classification
C01BG07
cibenzoline
Level 1: CARDIOVASCULAR SYSTEM
Level 2: CARDIAC THERAPY
Activity Summary
IC50 7 meas. best 5.11
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Sodium channel alpha subunit CHEMBL2331043 | IC50 | 5.11 | 5.11 | 7800.0 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 5.06 | 4.855 | 8800.0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1C CHEMBL2366456 | IC50 | 4.85 | 4.7367 | 14000.0 | 3 |
| Voltage-gated L-type calcium channel CHEMBL2095229 | IC50 | 4.52 | 4.52 | 30000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 28.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 8.6 | mL.min-1.kg-1 | Homo sapiens |
| CL | 4.4 | mL.min-1.kg-1 | Homo sapiens |
| CL | 8.6 | mL.min-1.kg-1 | Homo sapiens |
| CL | 8.6 | mL.min-1.kg-1 | Homo sapiens |
| F | 80.0 | % | Homo sapiens |
| Fu | 0.5 | - | Homo sapiens |
| Fu | 0.5 | - | Homo sapiens |
| MRT | 7.8 | hr | Homo sapiens |
| T1/2 | 7.3 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 20070106 | 10.1021/jm901371v | Homo sapiens | 8 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 18426954 | 10.1124/dmd.108.020479 | ADMET | 4 |
| 22761000 | 10.1002/jat.2784 | Voltage-dependent L-type calcium channel subunit alpha-1C | 3 |
| 37468498 | 10.1038/s41467-023-40064-9 | Thromboxane A2 receptor | 2 |
| 10891117 | 10.1021/jm0000564 | No relevant target | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Prostaglandin G/H synthase 1 | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Alpha-1A adrenergic receptor | 2 |
| 19445515 | 10.1021/jm900403j | Homo sapiens | 2 |
| 37468498 | 10.1038/s41467-023-40064-9 | Muscarinic acetylcholine receptor M1 | 2 |
| 10891117 | 10.1021/jm0000564 | ADMET | 2 |
| 18426954 | 10.1124/dmd.108.020479 | NON-PROTEIN TARGET | 1 |
| 20070106 | 10.1021/jm901371v | Plasma | 1 |
| 21300721 | 10.1093/cvr/cvr044 | Sodium channel alpha subunit | 1 |
| 21300721 | 10.1093/cvr/cvr044 | Voltage-gated L-type calcium channel | 1 |
| 21300721 | 10.1093/cvr/cvr044 | Voltage-gated inwardly rectifying potassium channel KCNH2 | 1 |
| 21300721 | 10.1093/cvr/cvr044 | ADMET | 1 |
| 19108654 | 10.1021/jm8008663 | ADMET | 1 |
| 23956101 | 10.1093/toxsci/kft176 | ATP-binding cassette sub-family C member 2 | 1 |
Data from ChEMBL 36 via Core Engine